- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03146832
Therapeutic Strategies During Exposure to Pain in an Experimental Design
July 3, 2017 updated by: Julia Anna Glombiewski, Philipps University Marburg Medical Center
Exposure Works, But How? Testing Different Therapeutic Strategies During Exposure to Pain in an Experimental Design
The goal of the present study is to compare different therapeutic strategies (according to habituation model vs. according to the inhibitory learning approach) during exposure to thermal pain in an experimental design.
Study Overview
Status
Completed
Conditions
Detailed Description
Exposure therapy is effective for the treatment of individuals with chronic pain and high levels of fear-avoidance.
Nevertheless, mechanisms of change for exposure treatment are not sufficiently investigated.
According to the habituation model, the activation of a fear structure leads to a habituation of the initial physical response.
Therefore, the therapeutic recommendation is to focus on the reduction of fear during exposure sessions.
According to the inhibitory learning approach, however, exposure experiences compete with the original US-CS fear association.
Therefore, the therapist should maximize the violation of negative expectancies.
The present study intends to compare both strategies during the exposure to pain in an experimental design.
Study Type
Interventional
Enrollment (Actual)
139
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marburg, Germany, 35037
- Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- female gender
- sufficient knowledge of German language
Exclusion Criteria:
- chronic and acute pain conditions
- Raynaud's disease
- high blood pressure
- neuropathy, coronary diseases
- diabetes, current alcohol
- drug or pain-medication (last 24hours)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Habituation
The habituation instruction focuses on changes of the initial physical fear-responses during exposure sessions.
It is explained that the level of anxiety will gradually decrease, or habituate, each time someone faces a feared situation.
Participants are then instructed to observe their own level of fear during the three practice trials with the thermode.
Together with the experimenter, participants have to indicate their level of arousal on an 11-point scale (0= neutral, 10 = very high) in-between and after the three practice trials.
After the practice trial, participants are instructed to reconsider their own development of physical responses.
Participants are encouraged to remember the development of their level of arousal during the test trail with the thermode.
|
Exposure instruction focuses on fear reduction during exposure sessions
|
|
Experimental: Expectation Violation
The expectation violation instruction focuses on the verification of negative expectancies during exposures sessions.
It is explained that exposure exercises help to create own experiences which allow to directly test negative predicted outcomes.
Together with the experimenter, participants are then encouraged to formulate concrete concerns in regard to the practice trail with the thermode.
Before the practice trails, participants have to indicate the likelihood of their concerns on an 11-point scale (0= not likely, 10 = very likely).
After the practice trails, participants are instructed to evaluate their own concerns by some guided questions (e.g.
"What did you learn?").
Participants are encouraged to keep their own experience in mind during the test trail with the thermode.
|
Exposure instruction focuses on expectation violation during exposure sessions
|
|
No Intervention: Control
Participants in the control group are not provided with information about exposure therapy.
Instead, participants listen to a newspaper article which reports on the daily work in a botanical garden.
Together with the experimenter, participants are then asked to name the most interesting aspect in the article.
Before the practice trails, participants have to rate how likely it is that they would further inform themselves about botanical gardens on an 11-point scale (0= not likely, 10 = very likely).
After the practice trails, participants are provided with some further questions about the newspaper article (e.g.
"Did you find the newspaper article interesting?").
This cognitive exercise does not cover any pain-related topics and, therefore, does not serve as a distraction instruction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain tolerance
Time Frame: 5 minutes prior and 5 minutes after three exposure practice trials
|
Determined by the temperature at which the participant stopped the heat stimulus
|
5 minutes prior and 5 minutes after three exposure practice trials
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: 5 minutes prior and 5 minutes after three exposure practice trials
|
Measured on an 11-point scale (0 = no pain; 10 = worst imaginable pain)
|
5 minutes prior and 5 minutes after three exposure practice trials
|
|
Pain quality
Time Frame: 5 minutes prior and 5 minutes after three exposure practice trials
|
Measured on an 11-points scale (0 = bearable; 10 = unbearable)
|
5 minutes prior and 5 minutes after three exposure practice trials
|
|
Pain Catastrophizing Scale (PCS)
Time Frame: 1-week prior and 10 minutes after three exposure practice trials
|
Pain catastrophizing thoughts (e.g.
"I worry all the time about whether the pain will end.")
|
1-week prior and 10 minutes after three exposure practice trials
|
|
Pain Anxiety Symptom Scale (PASS)
Time Frame: 1-week prior and 10 minutes after three exposure practice trials
|
Pain-related anxiety (e.g.
"I worry when I am in pain.")
|
1-week prior and 10 minutes after three exposure practice trials
|
|
Pain Processing (Fragebogen zur Erfassung der Schmerzverarbeitung, FESV)
Time Frame: 1-week prior and 10 minutes after three exposure practice trials
|
Cognitive pain coping strategies (e.g.
"When I am in pain, I know several possibilities how to handle them.")
|
1-week prior and 10 minutes after three exposure practice trials
|
|
Psychophysiological activation
Time Frame: throughout the experiment (5 minutes prior, during and 10 minutes after three exposure practice trails
|
e.g.
skin conductance responses, heart rate
|
throughout the experiment (5 minutes prior, during and 10 minutes after three exposure practice trails
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Julia Anna Glombiewski, Phd, Department of Clinical Psychology and Psychotherapy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2017
Primary Completion (Actual)
June 15, 2017
Study Completion (Actual)
June 15, 2017
Study Registration Dates
First Submitted
April 18, 2017
First Submitted That Met QC Criteria
May 9, 2017
First Posted (Actual)
May 10, 2017
Study Record Updates
Last Update Posted (Actual)
July 5, 2017
Last Update Submitted That Met QC Criteria
July 3, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-33v
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Acute
-
Rajavithi HospitalCompletedTotal Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , CelecoxibThailand
-
Umraniye Education and Research HospitalNot yet recruiting
-
Zagazig UniversityRecruiting
-
Ain Shams UniversityNot yet recruiting
-
Ain Shams UniversityNot yet recruitingPostoperative Pain, AcuteEgypt
-
Aga Khan UniversityRecruiting
-
Seoul National University HospitalCompletedPostoperative Pain, AcuteKorea, Republic of
-
Huazhong University of Science and TechnologyCompletedPostoperative Pain, Acute
-
Schulthess KlinikNot yet recruiting
-
Seoul National University HospitalNot yet recruiting
Clinical Trials on Exposure therapy (according to habituation approach)
-
Linkoeping UniversityCentre Hospitalier Universitaire Dijon; Bicetre Hospital; European Georges Pompidou... and other collaboratorsActive, not recruitingSepsis | Septic Shock | Cardiomyopathies | Organ Failure, MultipleFrance, Sweden
-
Sundsvall HospitalCompletedFemoral Neck FractureSweden
-
Ospedale Santa Croce-Carle CuneoNot yet recruitingPeritoneal Carcinosis | Early Stage Ovarian TumorsItaly
-
University of ZurichRecruitingPulmonary Hypertension Outcome AssessmentSwitzerland
-
Tufts UniversityNot yet recruiting
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedDepressive Disorder | Anxiety DisordersUnited States
-
Stockholm UniversityCompletedAnxiety | Social Phobia | Behavior TherapySweden
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Harvard UniversityAnnie E. Casey Foundation; MacArthur Foundation; Casey Family ProgramsCompletedDepression | Problem Behavior | Anxiety | TraumaUnited States